Indication:Antithrombotic action, mediated through inhibition of platelet activation, secondary prophylaxis following myocardial infarction and unstable angina or cerebral transient ischemic attacks.

Dosage & Administration:150 mg at diagnosis and 75 mg daily thereafter.

Preparation:Carva® 75 tablet: Box containing 20 x 10 tablets in strip pack.